Application and Generalization of Flutter Mucus Clearance Device

Application and Generalization of Flutter Mucus Clearance Device

The purpose of this study is to evaluate the clinical outcome and safety of flutter mucus clearance devices.

Respiratory diseases are still increasing in elder population. Sputum detaining is a common contributing factor to acute exacerbation. The fluttering mucus clearance technique is expected to be a physical assisting therapy enhancing airway secretion clearance but need more clinical randomized control trial evidence.

Inclusion Criteria:

• Pulmonary department: available to perform the device, in-hospital patients

  • Male and female
  • Age: 45 - 85 years
  • Chronic bronchitis, COPD

• Thoracic surgery department and surgical department (upper abdomen):

  • Patients with endotracheal intubation of general anesthesia
  • Age: 40-75 years

Exclusion Criteria:

• Not available to perform the procedure
• Untreated pneumothorax
• Diffusion interstitial lung disease
• Acute coronary syndrome
• Third stage hypertension
• Advanced cancer
• Severe heart, liver, renal , blood system and endocrine system dysfunction
• Noninvasive mechanical ventilation more than 6 hrs per day
• Patients with invasive ventilation and cannot weaning and extubation within 48 hours
• Active hemoptysis